Oriel Therapeutics
Latest round
- Series C
Last raised
- Nov 2007
Total raised
- $23M
Investors
- 3
About Oriel Therapeutics
Oriel Therapeutics is a specialty pharmaceutical company engages in the development of dry powder delivery systems for the treatment of asthma and COPD.
Who invested in Oriel Therapeutics
3 investors across 1 round
See all investors in Oriel Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Nov 16, 2007
Amount
$23M
Investors
Questions about Oriel Therapeutics
Who invested in Oriel Therapeutics?
Oriel Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oriel Therapeutics raised?
Oriel Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Oriel Therapeutics last raise money?
Oriel Therapeutics's most recent round on record is a Series C, in Nov 2007.
What does Oriel Therapeutics do?
Oriel Therapeutics is a specialty pharmaceutical company engages in the development of dry powder delivery systems for the treatment of asthma and COPD.
Where is Oriel Therapeutics headquartered?
Oriel Therapeutics is headquartered in Durham, US.
Which VCs invest in companies like Oriel Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Oriel Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Oriel Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.